BSEM BioStem Technologies, Inc.
$4.31▲ +3.23%
Healthcare
Other
After hours
$4.34▲ +0.70%
Sep 11, 7:31 PM ET
Volume 142.9K
Avg Volume (10D) 125.4K
Key Metrics & Fundamentals
Market Cap
$76.85M
P/E Ratio
4.9
Div Yield
–%
52W Range
2.25 - 8.40
% vs 50 MA
15.64%
% vs 200 MA
-6.35%
RSI-14
60.1
MACD Histogram
+0.0700
Beta (1Y vs SPY)
1.36
Gross Rev
$7.90M
Gross Profit
$4.84M
EBITDA
-$7.71M
COGS
$3.06M
Operating Exp
$13.24M
Operating Income
-$8.40M
EBIT
-$8.40M
Pretax Income
-$8.97M
Net Income
-$8.97M
EPS (Diluted)
-0.52
Price & Volume History
Loading chart…
Recent News
BioStem Technologies Opens Hospital Access for VENDAJE® and VENDAJE AC® Through Vizient and Premier
GlobeNewswire · Sep 4, 2026 11:00 AM
BioStem Technologies to Present at the H.C. Wainwright 28th Annual Global Investment Conference
GlobeNewswire · Sep 3, 2026 8:05 PM
BioStem Technologies Eyes Surgical Growth, Manufacturing Shift After BioTissue Deal
MarketBeat · Aug 22, 2026 1:01 AM
Sidoti Events, LLC's August Micro-Cap Virtual Conference
ACCESS Newswire · Aug 18, 2026 2:00 PM
BioStem Technologies to Present at the Sidoti MicroCap Conference
GlobeNewswire · Aug 14, 2026 8:05 PM
BioStem Technologies Inc (BSEM) (Q2 2026) Earnings Call Highlights: Revenue Surges to $7. ...
GuruFocus.com · Aug 13, 2026 5:03 AM
BioStem Technologies Q2 Earnings Call Highlights
MarketBeat · Aug 13, 2026 4:04 AM
BioStem Technologies, Inc. (BSEM) Reports Q2 Loss, Beats Revenue Estimates
Zacks · Aug 12, 2026 9:40 PM
BioStem Technologies Reports Second Quarter 2026 Financial Results
GlobeNewswire · Aug 12, 2026 8:05 PM
Codexis (CDXS) Reports Q2 Loss, Tops Revenue Estimates
Zacks · Aug 11, 2026 9:45 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See BSEM's money flow as a full page
Social Sentiment
No Reddit posts found for BSEM.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.